Marc T Goodman1, Ko Hui Tung. 1. Cancer Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813, USA. marc@crch.hawaii.edu
Abstract
OBJECTIVE: To examine the hypothesis that alcohol consumption is associated with the risk of ovarian cancer by conducting a population-based, case-control study in Hawaii and Los Angeles, California. METHODS: In-person interviews were obtained from 558 women with ovarian cancer and 607 population controls regarding lifetime alcohol consumption and other factors that may be related to the development of ovarian cancer. RESULTS: We found no overall association of alcohol drinking with the odds ratios (OR) for ovarian cancer. However, current alcohol drinkers, but not former drinkers, had a significantly lower OR for ovarian cancer compared with never drinkers (OR 0.69, 95% confidence interval [CI] 0.50, 0.96). Odds ratios for ovarian cancer associated with the current consumption of beer, wine, and spirits were also reduced, but were only significant for wine drinkers. Among current wine drinkers, women who drank red wine had a significantly reduced OR for ovarian cancer compared with never drinkers (OR 0.61, 95% CI 0.39, 0.94). The inverse association of current alcohol drinking with the OR for ovarian cancer was restricted to invasive tumors, especially the endometrioid cell type. The number of glasses of alcohol consumed on a weekly basis was inversely related to the OR for invasive ovarian cancer (P =.009): Current drinkers consuming 14 or more drinks per week had an OR of 0.36 (95% CI 0.19, 0.70) compared with never drinkers. A significantly increased risk of borderline serous tumors was associated with the use of spirits (OR 2.66, 95% CI 1.46, 4.85). The risk for borderline mucinous tumors was also significantly elevated for former wine drinkers. CONCLUSIONS: These findings suggest that the association of alcohol consumption with the OR for ovarian cancer may vary by alcohol type, tumor invasiveness, and histology.
OBJECTIVE: To examine the hypothesis that alcohol consumption is associated with the risk of ovarian cancer by conducting a population-based, case-control study in Hawaii and Los Angeles, California. METHODS: In-person interviews were obtained from 558 women with ovarian cancer and 607 population controls regarding lifetime alcohol consumption and other factors that may be related to the development of ovarian cancer. RESULTS: We found no overall association of alcohol drinking with the odds ratios (OR) for ovarian cancer. However, current alcohol drinkers, but not former drinkers, had a significantly lower OR for ovarian cancer compared with never drinkers (OR 0.69, 95% confidence interval [CI] 0.50, 0.96). Odds ratios for ovarian cancer associated with the current consumption of beer, wine, and spirits were also reduced, but were only significant for wine drinkers. Among current wine drinkers, women who drank red wine had a significantly reduced OR for ovarian cancer compared with never drinkers (OR 0.61, 95% CI 0.39, 0.94). The inverse association of current alcohol drinking with the OR for ovarian cancer was restricted to invasive tumors, especially the endometrioid cell type. The number of glasses of alcohol consumed on a weekly basis was inversely related to the OR for invasive ovarian cancer (P =.009): Current drinkers consuming 14 or more drinks per week had an OR of 0.36 (95% CI 0.19, 0.70) compared with never drinkers. A significantly increased risk of borderline serous tumors was associated with the use of spirits (OR 2.66, 95% CI 1.46, 4.85). The risk for borderline mucinous tumors was also significantly elevated for former wine drinkers. CONCLUSIONS: These findings suggest that the association of alcohol consumption with the OR for ovarian cancer may vary by alcohol type, tumor invasiveness, and histology.
Authors: Rhonda Arthur; Theodore M Brasky; Tracy E Crane; Ashley S Felix; Andrew M Kaunitz; Aladdin H Shadyab; Lihong Qi; Sylvia Wassertheil-Smoller; Thomas E Rohan Journal: Am J Epidemiol Date: 2019-02-01 Impact factor: 4.897
Authors: Tomas Riman; Paul W Dickman; Staffan Nilsson; Hans Nordlinder; Cecilia M Magnusson; Ingemar R Persson Journal: Eur J Epidemiol Date: 2004 Impact factor: 8.082
Authors: Margaret A Gates; Allison F Vitonis; Shelley S Tworoger; Bernard Rosner; Linda Titus-Ernstoff; Susan E Hankinson; Daniel W Cramer Journal: Int J Cancer Date: 2009-04-15 Impact factor: 7.396
Authors: Ellen T Chang; Alison J Canchola; Valerie S Lee; Christina A Clarke; David M Purdie; Peggy Reynolds; Leslie Bernstein; Daniel O Stram; Hoda Anton-Culver; Dennis Deapen; Harvey Mohrenweiser; David Peel; Rich Pinder; Ronald K Ross; Dee W West; William Wright; Argyrios Ziogas; Pamela L Horn-Ross Journal: Cancer Causes Control Date: 2007-02 Impact factor: 2.506
Authors: Linda E Kelemen; Elisa V Bandera; Kathryn L Terry; Mary Anne Rossing; Louise A Brinton; Jennifer A Doherty; Roberta B Ness; Susanne Krüger Kjaer; Jenny Chang-Claude; Martin Köbel; Galina Lurie; Pamela J Thompson; Michael E Carney; Kirsten Moysich; Robert Edwards; Clare Bunker; Allan Jensen; Estrid Høgdall; Daniel W Cramer; Allison F Vitonis; Sara H Olson; Melony King; Urmila Chandran; Jolanta Lissowska; Montserrat Garcia-Closas; Hannah Yang; Penelope M Webb; Joellen M Schildkraut; Marc T Goodman; Harvey A Risch Journal: BMC Cancer Date: 2013-01-22 Impact factor: 4.430
Authors: J M Genkinger; D J Hunter; D Spiegelman; K E Anderson; J E Buring; J L Freudenheim; R A Goldbohm; L Harnack; S E Hankinson; S C Larsson; M Leitzmann; M L McCullough; J Marshall; A B Miller; C Rodriguez; T E Rohan; A Schatzkin; L J Schouten; A Wolk; S M Zhang; S A Smith-Warner Journal: Br J Cancer Date: 2006-03-13 Impact factor: 7.640
Authors: Tomotaka Ugai; Linda E Kelemen; Mika Mizuno; Jue-Sheng Ong; Penelope M Webb; Georgia Chenevix-Trench; Kristine G Wicklund; Jennifer Anne Doherty; Mary Anne Rossing; Pamela J Thompson; Lynne R Wilkens; Michael E Carney; Marc T Goodman; Joellen M Schildkraut; Andrew Berchuck; Daniel W Cramer; Kathryn L Terry; Hui Cai; Xiao-Ou Shu; Yu-Tang Gao; Yong-Bing Xiang; David Van Den Berg; Malcom C Pike; Anna H Wu; Celeste Leigh Pearce; Keitaro Matsuo Journal: Cancer Sci Date: 2018-01-21 Impact factor: 6.716